Assessing Janus Kinase Inhibitor’s Place in Therapy in Established Rheumatoid Arthritis Patients-From a Simplified Indirect Comparison Versus Tumor Necrosis Factor Inhibitors to a Bayesian Probability of Response-The Value Of Transparency

October 30, 2013 GROWTH

AUTHORS: Ingham, M.P., Song, P., Cartier, S., Lawson-Remer, K. and Murray, E.

Publication: Arthritis and Rheumatism. Vol. 65. 111 River St, Hoboken 07030-5774, Nj Usa: Wiley-Blackwell, 2013. Presented at the 2013 Academy of Managed Care Pharmacy (AMCP) meeting, October 16-18 in San Diego, California.

YEAR: 2013

Read article

Assessing Janus Kinase Inhibitor's Place in Therapy